AtriCure gets FDA OK for Synergy ablation system

12/19/2011 | Reuters

The FDA has granted AtriCure approval for its Synergy ablation device for use in treating patients with atrial fibrillation during open-heart procedures. The Synergy system is the first such device to have been cleared for atrial fibrillation therapy in the U.S.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN